Skip to main content

Kidney Injury in Patients with Ventricular Assist Devices

  • Chapter
  • First Online:
Book cover Cardio-Nephrology

Abstract

Implantable left ventricular assist devices (LVADs) are an established treatment option for patients with end-stage heart failure (HF) that is refractory to conventional medical therapy. A significant proportion of these patients develop kidney impairment (KI) due to cardiorenal syndrome (CRS), which is often reversible following LVAD implantation, while others develop post-implantation acute kidney injury (AKI) or have chronic kidney disease (CKD) at implantation. The presence of KI has negative impact on clinical outcomes. It is associated with high mortality, lower cardiac transplantation rate, and potential outcome for long-term dialysis. Patients with LVADs who develop AKI necessitating renal replacement therapy (RRT) present unique challenges in their management and require an understanding of the hemodynamic and physiologic consequences of the LVAD during dialysis. This chapter discusses the effects of continuous blood flow on the kidney, various renal outcomes of patients following LVAD implantation, and management of RRT with LVAD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant. 2014;33(6):555–64.

    Article  PubMed  Google Scholar 

  2. Park SJ, Tector A, Piccioni W, Raines E, Gelijns A, Moskowitz A, et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg. 2005;129(1):9–17.

    Article  PubMed  Google Scholar 

  3. Patel UD, Hernandez AF, Liang L, Peterson ED, LaBresh KA, Yancy CW, et al. Quality of care and outcomes among patients with heart failure and chronic kidney disease: a get with the guidelines—Heart Failure Program study. Am Heart J. 2008;156(4):674–81.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kirklin JK, Naftel DC, Kormos RL, Pagani FD, Myers SL, Stevenson LW, et al. Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant. J Heart Lung Transplant. 2013;32(12):1205–13.

    Article  PubMed  Google Scholar 

  5. Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D, et al. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg. 2009;87(4):1072–8.

    Article  PubMed  Google Scholar 

  6. Yoshioka D, Sakaguchi T, Saito S, Miyagawa S, Nishi H, Yoshikawa Y, et al. Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: significance of INTERMACS level and renal function. Circ J. 2012;76(7):1631–8.

    Article  PubMed  Google Scholar 

  7. Iwashima Y, Yanase M, Horio T, Seguchi O, Murata Y, Fujita T, et al. Serial changes in renal function as a prognostic indicator in advanced heart failure patients with left ventricular assist system. Ann Thorac Surg. 2012;93(3):816–23.

    Article  PubMed  Google Scholar 

  8. Khot UN, Mishra M, Yamani MH, Smedira NG, Paganini E, Yeager M, et al. Severe renal dysfunction complicating cardiogenic shock is not a contraindication to mechanical support as a bridge to cardiac transplantation. J Am Coll Cardiol. 2003;41(3):381–5.

    Article  PubMed  Google Scholar 

  9. Singh M, Shullo M, Kormos RL, Lockard K, Zomak R, Simon MA, et al. Impact of renal function before mechanical circulatory support on posttransplant renal outcomes. Ann Thorac Surg. 2011;91(5):1348–54.

    Article  PubMed  Google Scholar 

  10. Mao H, Katz N, Kim JC, Day S, Ronco C. Implantable left ventricular assist devices and the kidney. Blood Purif. 2014;37(1):57–66.

    Article  PubMed  Google Scholar 

  11. Wilson SR, Mudge GH Jr, Stewart GC, Givertz MM. Evaluation for a ventricular assist device: selecting the appropriate candidate. Circulation. 2009;119(16):2225–32.

    Article  PubMed  Google Scholar 

  12. Imamura T, Kinugawa K, Shiga T, Kato N, Endo M, Inaba T, et al. How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients? J Artif Organs. 2012;15(4):395–8.

    Article  PubMed  Google Scholar 

  13. Saito S, Westaby S, Piggot D, Dudnikov S, Robson D, Catarino PA, et al. End-organ function during chronic nonpulsatile circulation. Ann Thorac Surg. 2002;74(4):1080–5.

    Article  PubMed  Google Scholar 

  14. Nemoto M. Experimental evaluation of the influence of complete artificial circulation on renal circulation and tissue metabolism-comparative study of pulsatile vs nonpulsatile circulation. Ann Thorac Cardiovasc Surg. 2003;9(6):355–64.

    PubMed  Google Scholar 

  15. Kihara S, Litwak KN, Nichols L, Litwak P, Kameneva MV, Wu Z, et al. Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist. Ann Thorac Surg. 2003;75(1):178–83 (discussion 83).

    Article  PubMed  Google Scholar 

  16. Ohnishi H, Itoh T, Nishinaka T, Tatsumi E, Fukuda T, Oshikawa M, et al. Morphological changes of the arterial systems in the kidney under prolonged continuous flow left heart bypass. Artif Organs. 2002;26(11):974–9.

    Article  PubMed  Google Scholar 

  17. Ootaki C, Yamashita M, Ootaki Y, Kamohara K, Weber S, Klatte RS, et al. Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system. J Thorac Cardiovasc Surg. 2008;136(1):150–8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Tromp TR, Nguyen TQ, de Jonge N, Joles JA. Absence of structural lesions in human renal arcuate arteries after LVAD implantation: response to a letter regarding “left ventricular assist devices: a kidney’s perspective”. Heart Fail Rev. 2015;20(6):753–4.

    Article  PubMed  Google Scholar 

  19. Welp H, Rukosujew A, Tjan TD, Hoffmeier A, Kosek V, Scheld HH, et al. Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure. Thorac Cardiovasc Surg. 2010;58(Suppl 2):S185–8.

    Article  PubMed  Google Scholar 

  20. Cooper TK, Griffith JW, Reibson J, Peterson R, Roush EP, Zhong Q, et al. Antibiotic-associated eosinophilic and occlusive arteritis in calves complicating preclinical studies of left ventricular assist devices. Toxicol Pathol. 2013;41(3):519–27.

    Article  PubMed  Google Scholar 

  21. Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(4 Suppl):S1–39.

    Article  PubMed  Google Scholar 

  22. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357(9):885–96.

    Article  CAS  PubMed  Google Scholar 

  23. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transplant. 2007;26(8):815–8.

    Article  PubMed  Google Scholar 

  24. Hasin T, Topilsky Y, Schirger JA, Li Z, Zhao Y, Boilson BA, et al. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol. 2012;59(1):26–36.

    Article  PubMed  Google Scholar 

  25. Deo SV, Sharma V, Altarabsheh SE, Hasin T, Dillon J, Shah IK, et al. Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device. Heart Lung Circ. 2014;23(3):229–33.

    Article  PubMed  Google Scholar 

  26. Brisco MA, Kimmel SE, Coca SG, Putt ME, Jessup M, Tang WW, et al. Prevalence and prognostic importance of changes in renal function after mechanical circulatory support. Circ Heart Fail. 2014;7(1):68–75.

    Article  PubMed  Google Scholar 

  27. Tromp TR, de Jonge N, Joles JA. Left ventricular assist devices: a kidney’s perspective. Heart Fail Rev. 2015;20(4):519–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Patel AM, Adeseun GA, Ahmed I, Mitter N, Rame JE, Rudnick MR. Renal failure in patients with left ventricular assist devices. Clin J Am Soc Nephrol. 2013;8(3):484–96.

    Article  PubMed  Google Scholar 

  29. Amir O, Radovancevic B, Delgado RM III, Kar B, Radovancevic R, Henderson M, et al. Peripheral vascular reactivity in patients with pulsatile vs axial flow left ventricular assist device support. J Heart Lung Transplant. 2006;25(4):391–4.

    Article  PubMed  Google Scholar 

  30. Demirozu ZT, Etheridge WB, Radovancevic R, Frazier OH. Results of HeartMate II left ventricular assist device implantation on renal function in patients requiring post-implant renal replacement therapy. J Heart Lung Transplant. 2011;30(2):182–7.

    Article  PubMed  Google Scholar 

  31. Borgi J, Tsiouris A, Hodari A, Cogan CM, Paone G, Morgan JA. Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation. Ann Thorac Surg. 2013;95(1):163–9.

    Article  PubMed  Google Scholar 

  32. Lok SI, Martina JR, Hesselink T, Rodermans BF, Hulstein N, Winkens B, et al. Single-centre experience of 85 patients with a continuous-flow left ventricular assist device: clinical practice and outcome after extended support. Eur J Cardiothorac Surg. 2013;44(3):e233–8.

    Article  PubMed  Google Scholar 

  33. John R, Naka Y, Smedira NG, Starling R, Jorde U, Eckman P, et al. Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. Ann Thorac Surg. 2011;92(4):1406–13 (discussion 13).

    Article  PubMed  Google Scholar 

  34. Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125(25):3191–200.

    Article  PubMed  Google Scholar 

  35. Strueber M, Larbalestier R, Jansz P, Zimpfer D, Fiane AE, Tsui S, et al. Results of the post-market Registry to Evaluate the HeartWare Left Ventricular Assist System (ReVOLVE). J Heart Lung Transplant. 2014;33(5):486–91.

    Article  PubMed  Google Scholar 

  36. Sandner SE, Zimpfer D, Zrunek P, Dunkler D, Schima H, Rajek A, et al. Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. J Heart Lung Transplant. 2008;27(5):469–73.

    Article  PubMed  Google Scholar 

  37. Genovese EA, Dew MA, Teuteberg JJ, Simon MA, Bhama JK, Bermudez CA, et al. Early adverse events as predictors of 1-year mortality during mechanical circulatory support. J Heart Lung Transplant. 2010;29(9):981–8.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113(5):671–8.

    Article  PubMed  Google Scholar 

  39. Topkara VK, Dang NC, Barili F, Cheema FH, Martens TP, George I, et al. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant. 2006;25(4):404–8.

    Article  PubMed  Google Scholar 

  40. Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH. Predictors of acute renal dysfunction after ventricular assist device placement. J Card Fail. 2009;15(10):874–81.

    Article  PubMed  Google Scholar 

  41. James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation. 1995;92(9 Suppl):II191–5.

    Article  CAS  PubMed  Google Scholar 

  42. Lampert BC, Eckert C, Weaver S, Scanlon A, Lockard K, Allen C, et al. Blood pressure control in continuous flow left ventricular assist devices: efficacy and impact on adverse events. Ann Thorac Surg. 2014;97(1):139–46.

    Article  PubMed  Google Scholar 

  43. Saritas T, Brandenburg V, Federico G, Grone HJ, Floege J, Moeller MJ, et al. Glomerulonephritis triggered by a chronically infected left ventricular assist device. Lancet. 2015;386(10010):2363–4.

    Article  PubMed  Google Scholar 

  44. Yanagida R, Czer LS, Ruzza A, Schwarz ER, Simsir SA, Jordan SC, et al. Use of ventricular assist device as bridge to simultaneous heart and kidney transplantation in patients with cardiac and renal failure. Transplant Proc. 2013;45(6):2378–83.

    Article  CAS  PubMed  Google Scholar 

  45. Karamlou T, Welke KF, McMullan DM, Cohen GA, Gelow J, Tibayan FA, et al. Combined heart-kidney transplant improves post-transplant survival compared with isolated heart transplant in recipients with reduced glomerular filtration rate: analysis of 593 combined heart-kidney transplants from the United Network Organ Sharing Database. J Thorac Cardiovasc Surg. 2014;147(1):456–61.

    Article  PubMed  Google Scholar 

  46. Leeser DB, Jeevanandam V, Furukawa S, Eisen H, Mather P, Silva P, et al. Simultaneous heart and kidney transplantation in patients with end-stage heart and renal failure. Am J Transplant. 2001;1(1):89–92.

    Article  CAS  PubMed  Google Scholar 

  47. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435–43.

    Article  CAS  PubMed  Google Scholar 

  48. Myers TJ, Bolmers M, Gregoric ID, Kar B, Frazier OH. Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J Heart Lung Transplant. 2009;28(5):423–7.

    Article  PubMed  Google Scholar 

  49. Frazier OH, Myers TJ, Westaby S, Gregoric ID. Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection. Ann Thorac Surg. 2004;77(1):133–42.

    Article  CAS  PubMed  Google Scholar 

  50. Patel AM, Eduardo Rame J, Rudnick MR. How does the nephrologist manage an LVAD patient on chronic maintenance dialysis? Semin Dial. 2014;27(3):284–8.

    Article  PubMed  Google Scholar 

  51. Quader MA, Kumar D, Shah KB, Fatani YI, Katlaps G, Kasirajan V. Safety analysis of intermittent hemodialysis in patients with continuous flow left ventricular assist devices. Hemodial Int. 2014;18(1):205–9.

    Article  PubMed  Google Scholar 

  52. Thomas BA, Logar CM, Anderson AE. Renal replacement therapy in congestive heart failure requiring left ventricular assist device augmentation. Perit Dial Int. 2012;32(4):386–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Guglielmi AA, Guglielmi KE, Bhat G, Siemeck R, Tatooles AJ. Peritoneal dialysis after left ventricular assist device placement. ASAIO J. 2014;60(1):127–8.

    Article  CAS  PubMed  Google Scholar 

  54. Labban B, Arora N, Restaino S, Markowitz G, Valeri A, Radhakrishnan J. The role of kidney biopsy in heart transplant candidates with kidney disease. Transplantation. 2010;89(7):887–93.

    Article  PubMed  Google Scholar 

  55. Cantarovich M, Blydt-Hansen TD, Gill J, Tinckam K, Schiff J, Alwayn I, et al. Canadian forum on combined organ transplantation. Transplantation. 2015 Nov 19. 2016;100:1339–48.

    Google Scholar 

  56. Papafragkakis H, Martin P, Akalin E. Combined liver and kidney transplantation. Curr Opin Organ Transplant. 2010;15(3):263–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This material is the result of work supported with resources and the use of facilities at the Baltimore VA Medical Center, MD.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ami M. Patel .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Patel, A.M., Kapoor, K., Rudnick, M.R. (2017). Kidney Injury in Patients with Ventricular Assist Devices. In: Rangaswami, J., Lerma, E., Ronco, C. (eds) Cardio-Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-319-56042-7_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56042-7_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56040-3

  • Online ISBN: 978-3-319-56042-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics